Download Clinical Microbiology and Infection

Clinical Microbiology and Infection
VOLUME 11, SUPPLEMENT 2, APRIL 2005
15th European Congress of Clinical
Microbiology and Infectious Diseases
Copenhagen, Denmark
2–5 April 2005
Page
1
1
3
3
4
4
5
6
6
7
8
8
9
9
14
17
18
20
23
23
23
24
24
26
28
30
31
32
33
33
38
Antibiotic sensitivity testing of anaerobic bacteria – Workshop arranged by ESGARAB
History of medical microbiology in Denmark
Update on toxoplasmosis (Symposium arranged with ESGT)
European guidelines for diagnosis of tick borne diseases (Symposium arranged with
ESCAR)
Vancomycin- and methicillin-resistant Staphylococcus aureus (VMRSA): how to cope with it in
the hospital setting? (Symposium arranged with ESGNI)
Management of relapses and outbreaks of Clostridium difficile (Symposium arranged with
ESGCD)
Antibiotics for lower respiratory tract infections in primary care (Symposium arranged with
ESPRIT)
Antibiotic use and policies: an in-depth look at ARPAC results (Symposium arranged with
ESGAP)
Is the commensal anaerobic microflora involved in spreading antibiotic resistance?
(Symposium arranged with ESGARAB)
Malaria control – what is in the pipeline?
Pseudomonas aeruginosa: a rogue bacterium in the intensive care unit (Symposium arranged
with ESICM)
Tuberculosis: persistence and resistance
Clinical microbiology: what’s new in conventional and molecular diagnostics? (Symposium
arranged with ESGMD)
Antibiotic usage: practices and policy interventions
Hepatitis virus
From mild to severe respiratory tract infection: what’s new with azalides? (Symposium
arranged by PLIVA)
Emerging viral infections
Advances in febrile neutropenia
The impact of beta-lactamases on clinical practice
The year in HIV medicine
Coping with the severe acute respiratory syndrome
Advances in foreign body infections
Paediatric infections
New typing approaches for MRSA control
Pharmacokinetics and pharmacodynamics of antibiotics
Genetic typing for important viral infections: recent technological and conceptual
developments (Symposium arranged with ESGEM)
Modifying the ribosome as a mechanism of resistance (Joint symposium arranged with
ICAAC)
Patterns of antibiotic stewardship, use and resistance in European hospitals (Joint symposium
arranged with ARPAC and ESAC)
Combination antifungal therapy (Symposium arranged with EFISG)
New diagnostic methods for the laboratory
Hospital infection: new sources and solutions
Contents
41
43
44
44
48
52
55
56
56
56
57
58
59
59
60
62
62
66
69
73
74
75
76
77
81
85
88
89
89
90
90
92
93
93
94
99
106
114
123
127
133
136
143
148
159
163
165
171
174
182
190
200
205
212
216
221
230
New antibacterials for the decade: strategies to deliver agents with novel actions (Symposium
arranged by GlaxoSmithKline)
Staphylococcus aureus disease – from basic science to clinical practice
Benchmarking nosocomial infections (Symposium co-organised by SHEA and ESGNI)
Exotic infections
Emergence and molecular evolution of antibiotic resistance
Predictors of the clinical course of HIV infection and therapy
Antimicrobial growth promoters in food animal production
Crosstalk between bacterial pathogens and their host cells
Infection control: challenges now and ahead
Burkholderia, Pseudomonas and emerging infections in cystic fibrosis
Climate and environment: impact on infectious diseases
Crimean Congo haemorrhagic fever in south-eastern Europe
Computerised decision support for management of bacterial infections
Hepatitis C virus: new targets for drug and vaccine development and markers for therapy
Focus on Mycobacterium tuberculosis
Diagnosis and management of sepsis in the critically-ill patient (Symposium arranged with
ISF)
MRSA – new challenges in hospital and community settings
Focus on extraction and amplification controls in molecular diagnostics
New developments in epidemiology of antibiotic resistance
Bacterial biofilms
Focus on new antibacterials
Emerging infections in the immuno-compromised host (Symposium arranged with EORTC/
IDSG)
Community-acquired MRSA in Europe – evolution at work
Recent trends in severe fungal infections
Antibiotic and antibiotic resistance mechanisms
Infections in the community: epidemiology, diagnosis and outcome
Metallo-beta-lactamases: a last frontier for beta-lactams?
Social-political consequences of the HIV pandemic: are we turning the tide?
Evolution and function of the haemagglutinin of the influenza virus
Streptococcus pneumoniae: a clonal war?
Recent advances in chlamydiology
Resistance to antifungal drugs
Emerging enteric pathogens: responding to the challenge
Influenza vaccination
New drugs to fight the resistance challenge
Metallo-beta-lactamases and resistance to carbapenems
Epidemiology of ESBL and MBL – I
Extended-spectrum beta-lactamase and other beta-lactamases
Various antimicrobial agents including disinfectants
Urinary tract infections
Borrelia
Antibiotic usage
Antibiotic policy intervention
Tuberculosis: diagnosis, resistance and immunology
Brucella
Toxoplasmosis
Clinical mycology
Clinical use of vaccines
Molecular methods for respiratory bacterial pathogens
Molecular methods for enteric pathogens
HIV
HCV: risk factors, diagnosis, clinical presentation and treatment
Bacteriology: role of selective media and identification systems
16S rRNA
Clinical mycology: case reports
Enterococci: epidemiology and resistance
Epidemiology of ESBL and MBL – II
Contents
238
246
253
259
264
266
271
280
284
291
292
299
302
314
326
328
334
338
341
346
350
354
361
366
376
381
388
391
401
408
411
414
423
435
439
442
449
456
461
469
478
483
486
489
494
499
504
514
516
519
524
527
531
536
546
551
554
561
563
569
Tigecycline, in vitro studies
Sexually transmitted diseases
Helicobacter
MRSA – virulence, genes, VISA and treatment
Training, scientific output in infectious disease
Pneumonia
Pharmacokinetics/pharmacodynamics of antibacterial drugs
Organ transplants
Exotic infections – I: case series
Infection and immunopathology
Staphylococcal infections
Mechanisms of resistance in staphylococci
Typing and epidemiology of MRSA
Antibiotic-resistant pneumococci and streptococci
Wound and fungal infections
Antibiotic resistance: nosocomial pathogens
Difficult to treat nosocomial infections
Susceptibility surveillance studies
Pharmacokinetics/pharmacodynamics of quinolones
Pharmacokinetics/pharmacodynamics of antifungals
Infection control: environmental and hand disinfection
Exotic infections – II
Fungal susceptibility testing
Skin and soft tissue infections
Fluroquinolones, in vitro studies
Antibacterial susceptibility studies – I
Mechanisms of resistance to macrolides
Paediatric infections
Mechanisms of antibiotic resistance in Gram-negative bacilli
Public health, surveillance and geographic information systems
Endocarditis
Enteric infection
Respiratory tract infection
Pneumococcal pneumonia
Pneumonia in non-HIV immunosuppressed patients
Detection of methicillin resistance
Infections and diagnosis in non-HIV immunosuppressed patients
Mechanisms of resistance to quinolones
Antibacterial susceptibility studies – II
Antibiotic-resistant community-acquired pathogens – I
Fungal diagnostics
ELISA-based diagnostics
Clostridium difficile
Chlamydia trachomatis
Hepatitis A, B and E viruses
Herpes virus
New drugs: in vitro studies
New drugs: in vivo studies
Pharmacokinetics/pharmacodynamics of anti-staphyloccal drugs
Infections in neutropenic patients
Procalcitonin, other markers of infection
Diagnosis of viral infections: new methods
Diagnosis of viral infections: respiratory and herpes viruses
Biofilms: pathogenesis and antibiotic susceptibility
CNS infections
Experimental CNS infections
Bloodstream infection
Catheter-related infections
Molecular bacteriology and mycology
Antifungal susceptibility studies
Contents
575
583
585
592
597
609
616
622
628
634
636
648
651
651
654
659
661
667
673
685
692
695
697
699
706
710
718
720
722
724
725
730
734
737
739
742
742
745
771
Pathogenesis of respiratory tract and other infections
Adverse drug reactions, probiotics
Antibiotic-resistant community-acquired pathogens – II
Pathogenesis of infections
Non-fermenter Gram-negative bacilli: epidemiology and resistance
Immunology, host defences, immunotherapy
Antibiotic resistance: nosocomial pathogens
Susceptibility testing methods
Surveillance of nosocomial infections
Environmental impact on nosocomial infections
Tuberculosis: clinical aspects and surveillance
Health care issues, public health, pharmaco-economics
New drugs
Pharmacokinetics, pharmacodynamics, drug interactions, tolerability
In vitro activity of antimicrobial agents
Mechanisms of action and of resistance of antimicrobial drugs
Epidemiology of resistance, antibiotic usage
Community-acquired infections
Nosocomial infections, infection control
Infection in the immunocompromised host (except HIV)
Immunology, host defenses, immunotherapy
Pathogenesis, animal models including experimental treatment
Molecular bacteriology (incl. diagnostics)
Diagnostic methods (other than molecular)
Mycobacterial infections (incl. diagnostics)
Fungal infections
Tropical and parasitic diseases
Sexually transmitted diseases (except HIV)
Molecular virology (incl. diagnostics)
Viral diseases (not HIV, Herpes, Hepatitis)
AIDS and HIV infection
Hepatitis
Herpes virus
Emerging infectious diseases
Vaccines
Infection in transplant recipients
Paediatric infections
Author index
Subject index